AIM ImmunoTech
32 hedge funds and large institutions have $919K invested in AIM ImmunoTech in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
7% more funds holding
Funds holding: 30 → 32 (+2)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
62% less capital invested
Capital invested by funds: $2.43M → $919K (-$1.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$16.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.88K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$4.19K |
| 4 |
Renaissance Technologies
New York
|
+$4.01K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.17M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 3 |
VF
Virtu Financial
New York
|
-$15.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$3.89K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$2.97K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $171 | +$210 | +9 | New |
|
27
Bank of America
Charlotte,
North Carolina
| $95 | +$23 | +1 | +25% |
|
28
Wells Fargo
San Francisco,
California
| $79 | – | – | – |
|
|
TWC
29
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $33 | – | – | – |
|
|
FFA
30
Farther Finance Advisors
San Francisco,
California
| $30 | – | – | – |
|
31
JP Morgan Chase
New York
| $28 | – | – | – |
|
|
HNB
32
Huntington National Bank
Columbus,
Ohio
| $11 | – | – | – |
|
|
MCM
33
MAI Capital Management
Independence,
Ohio
| $6 | – | – | – |
|
34
UBS Group
Zurich,
Switzerland
| $4 | – | – | – |
|
|
AC
35
Armistice Capital
New York
| – | -$1.17M | -43,343 | Closed |
|
|
BCM
36
Bridgeway Capital Management
Houston,
Texas
| – | -$2.97K | -110 | Closed |
|
37
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$162 | -6 | Closed |
|
AIM Hedge Fund Activity: Q4 2024 in Review
32 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2024, worth a combined $919K — down 62% from $2.43M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AIM positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $16.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.17M sold.
- 32 institutional investors held AIM ImmunoTech (AIM) as of Q4 2024, up from 30 in Q3 2024.
- Funds reported $919K of AIM ImmunoTech stock for Q4 2024, down 62% quarter-over-quarter.
- 5 funds opened new AIM ImmunoTech positions in Q4 2024 and 3 closed out, a net change of +2 holders.
- The largest AIM ImmunoTech buyer in Q4 2024 was Two Sigma Securities, an estimated $16.6K added.
- The largest AIM ImmunoTech seller in Q4 2024 was Armistice Capital, an estimated $1.17M sold.
Based on aggregated 13F filings for Q4 2024.